Cite
HARVARD Citation
Kivitz, A. et al. (n.d.). Subcutaneous Tocilizumab Versus Placebo in Combination With Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis1. Arthritis care & research. 66 (11), pp. 1653-1661. [Online].